XML 23 R12.htm IDEA: XBRL DOCUMENT
v3.21.2

Accrued Expenses and Other Current Liabilities | 6 Months Ended
--- | ---
Jun. 30, 2021
Payables And Accruals [Abstract] |
Accrued Expenses and Other Current Liabilities | 4. ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES Accrued expenses and other current liabilities consist of the following (in thousands):
|  | June 31, 2021 |  |  | December 31, 2020 |
Accrued offering costs |  | $ | 806 |  |  | $ | 876 |
Accrued clinical trials |  |  | 300 |  |  |  | 376 |
Accrued compensation |  |  | 340 |  |  |  | 400 |
Accrued other |  |  | 39 |  |  |  | 126 |
Total accrued expenses and other current liabilities |  | $ | 1,485 |  |  | $ | 1,778 |

X
- Definition The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period. + References No definition available. + Details
Name: | us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration